Core Viewpoint - The company, North Huachuang, reported steady growth in its semiconductor business for the first half of 2025, with a strong order backlog and expectations for continued year-on-year growth despite seasonal revenue fluctuations in Q2 2025 [2][3]. Financial Performance - Q2 2025 revenue was 7.94 billion yuan, a year-on-year increase of 22.5% but a quarter-on-quarter decrease of 3.3%, attributed to seasonal revenue recognition [2]. - Gross margin for Q2 2025 was 41.3%, down 6.1 percentage points year-on-year and 1.7 percentage points quarter-on-quarter [2]. - Net profit attributable to shareholders for Q2 2025 was 1.63 billion yuan, a year-on-year decrease of 1.6% but a quarter-on-quarter increase of 3% [2]. - For the first half of 2025, electronic process equipment revenue reached 15.26 billion yuan, up 33.9% year-on-year, with a gross margin of 41.7%, down 2.93 percentage points year-on-year [2][3]. Business Segments - The semiconductor equipment segment showed robust growth, with revenue from North Huachuang's semiconductor equipment reaching 14.8 billion yuan, a year-on-year increase of 35.4%, and net profit of 3.26 billion yuan, up 20% [3]. - The electronic components segment faced challenges, with revenue of 868 million yuan, down 17.5% year-on-year, and a gross margin of 50.4%, down 7 percentage points [2][3]. Product Development - The company continues to enhance its process coverage, successfully launching new products such as ion implantation machines and electroplating machines [3]. - In H1 2025, revenue from etching equipment exceeded 5 billion yuan, thin film deposition equipment exceeded 6.5 billion yuan, thermal processing equipment exceeded 1 billion yuan, and wet processing equipment exceeded 500 million yuan [3]. Investment Outlook - The company is expected to achieve revenues of 38.52 billion yuan, 48.36 billion yuan, and 59.41 billion yuan for 2025, 2026, and 2027 respectively, with net profits of 7.43 billion yuan, 9.64 billion yuan, and 12.1 billion yuan, corresponding to P/E ratios of 38.5, 29.7, and 23.7 [3].

点击招商研究小程序查看PDF报告原文 事件：华海清科发布2025半年报，公司25Q2收入利润同环比稳健增长，毛利率和净利率维持较高水 平。公司CMP设备先进制程签单实现较大占比，减薄、划切、离子注入机等新品进展顺利，晶圆再生 产能持续爬坡。***投资评级。 25Q2收入同环比稳健增长，盈利能力提升。 ①25H1收入19.5亿元，同比+30.3%；归母净利润5.1亿元， 同比+16.8%；扣非净利润4.6亿元，同比+25%。公司利润增速低于收入增速，主要系职工薪酬增长以及 收购芯嵛公司影响，期间费用率增速较快，同时利息收入和政府补助等减少；②25Q2收入10.4亿元，同 比+27%/环比+13.7%；毛利率45.8%，同比+0.9pct/环比-0.5pct；归母净利润2.7亿元，同比+18%/环比 +16.5%；扣非净利润2.5亿元，同比+26.3%/环比+17%。公司整体收入稳健增长，盈利能力保持在较高 水平。 新签CMP设备订单中先进制程占比提升，减薄机等订单大幅增长。 公司全新抛光系统架构机台 Universal-H300获得批量重复订单，实现规模化出货，新签CMP设备订单中先进制程实现较大占比，部 分先 ...

Core Viewpoint - The company reported significant revenue growth in Q2 2025, with a focus on increasing R&D investment to accelerate the launch of new products, particularly in etching equipment for advanced process lines [2][3]. Financial Performance - In H1 2025, the company's revenue reached 4.96 billion yuan, a year-on-year increase of 43.9%, while net profit attributable to shareholders was 710 million yuan, up 36.6% year-on-year [2]. - Q2 2025 revenue was 2.79 billion yuan, reflecting a year-on-year growth of 51.3% and a quarter-on-quarter increase of 28.3% [2]. - The gross margin for Q2 was 38.5%, showing a slight year-on-year increase of 0.4 percentage points but a decrease of 3 percentage points quarter-on-quarter [2]. - The company's R&D expenses in H1 2025 amounted to 1.116 billion yuan, a significant increase of 96.7% year-on-year, impacting short-term profit performance [2]. Product Development and Market Position - The revenue from etching equipment in H1 2025 was approximately 3.78 billion yuan, representing a year-on-year increase of 40%, while LPCVD equipment revenue surged to 199 million yuan, up 608% year-on-year [3]. - The company has successfully increased the shipment volume of high-end products for critical etching processes in advanced logic and memory device manufacturing, achieving large-scale production [3]. - The company is progressing well with the validation of new EPI equipment, entering the advanced process and customer validation stages [3]. Investment Recommendation - The company maintains a positive outlook for revenue growth in 2025, 2026, and 2027, with a recommendation to "increase holdings" based on the current performance and future potential [3].

Group 1: Financial Performance - The projected net profit for 2025 is estimated at 605 million RMB, reflecting a growth rate of 52% compared to 2024[1] - The expected operating revenue for 2025 is 4,157 million RMB, with a growth rate of 4% from 2024[1] - The estimated EPS for 2025 is 0.6, with a PE ratio of 18[1] Group 2: Market Trends and Risks - The valuation for 2025-2027 is projected at 18x, 16x, and 14x, with a PEG ratio of less than 1 for 2026[1] - The company is expected to launch innovative and hard-to-replicate products, including a new drug expected to be approved in 2025[1] - Risks include fluctuations in customer demand and potential delays in product development[1] Group 3: Industry Insights - The pharmaceutical industry is experiencing a gradual recovery, with the raw material drug business stabilizing[1] - The beverage industry is expected to see improved sales during the Mid-Autumn Festival and National Day, with a narrowing decline[1] - The semiconductor equipment sector is projected to achieve significant revenue growth, with a target of 5 billion RMB by 2025[1]

Investment Rating - The report maintains a "Strong Buy" rating for the company, expecting it to outperform the benchmark index by over 20% in the next six months [2][22]. Core Views - The company has demonstrated robust revenue growth, driven by opportunities in the advanced packaging market fueled by AI technology. The company achieved a revenue of 1.95 billion yuan in the first half of 2025, representing a year-on-year increase of 30.28%, and a net profit of 505 million yuan, up 16.82% year-on-year [3][7]. - The company is actively developing new products and technologies, enhancing its market competitiveness. It focuses on semiconductor key equipment and technology services, continuously updating existing products and expanding into new technologies [7]. - The construction of new production bases is accelerating, optimizing the company's industrial layout. The Beijing plant has commenced operations, and the company is expanding its capacity in the wafer regeneration project in Kunshan [7]. Financial Summary - Total revenue is projected to grow from 3.41 billion yuan in 2024 to 6.89 billion yuan in 2027, with a compound annual growth rate (CAGR) of 35.8% to 16.7% [3][8]. - Net profit attributable to the parent company is expected to increase from 1.02 billion yuan in 2024 to 1.98 billion yuan in 2027, with a CAGR of 41.4% to 17.0% [3][8]. - Earnings per share (EPS) is forecasted to rise from 2.90 yuan in 2024 to 5.60 yuan in 2027, reflecting strong profitability growth [3][8].

Core Insights - In the first half of 2025, the company achieved a revenue of approximately 4.961 billion yuan, representing a year-on-year growth of about 43.88% [1] - The net profit attributable to the parent company was approximately 706 million yuan, with a year-on-year increase of about 36.62% [1] - The company's R&D investment totaled 1.492 billion yuan, an increase of 53.70% year-on-year, accounting for 30.07% of its revenue [1] Revenue and Profit Growth - The sales revenue from etching equipment was approximately 3.781 billion yuan, up by about 40.12% year-on-year [2] - LPCVD equipment sales reached approximately 199 million yuan, showing a significant increase of 608.19% [2] - The company has achieved large-scale production of various key etching processes in advanced logic and storage devices, contributing to strong revenue growth [2] Market Position and Product Development - The company’s etching equipment now covers over 95% of etching applications, extending its technological capabilities to 5nm and more advanced processes [2] - The company has a strong patent portfolio with 3,038 applications filed, including 2,507 invention patents, and 1,901 patents granted [5] - The company is expanding its product layout in the semiconductor micro-manufacturing field, including MOCVD equipment for GaN-based devices and new TSV deep silicon etching equipment [6] R&D and Innovation - The company employs a three-tiered R&D model focusing on "pre-research, mass production, and iteration," with a strong emphasis on advanced process technology below 5nm [6] - The R&D process is organized into independent teams for different product categories, optimizing resource use and enhancing innovation [5] - The company’s R&D investment intensity exceeds revenue proportion, ensuring a technological edge in the market [6] Industry Outlook - The semiconductor manufacturing equipment sales are projected to reach $130 billion by 2026, with China and South Korea being major spending regions [7] - The company’s founder has over 40 years of industry experience, contributing to its strong market position and technological advancements [7] - The company has established a business model that combines equipment sales with process validation and service, creating a stable cash flow and reducing risks associated with equipment cycles [8]

Investment Rating - The investment rating for the company is "Accumulate" [1] Core Views - The company reported steady growth in its H1 2025 performance, benefiting from the expansion of advanced process manufacturing [2][3] - The semiconductor equipment business experienced rapid growth, with H1 2025 revenue reaching 16.142 billion yuan, a year-on-year increase of 29.51% [3] - The company's gross profit margin showed fluctuations, leading to a slight decline in profitability levels in H1 2025 [4] - The platform layout is expected to benefit from the expansion of advanced processes, with strategic acquisitions enhancing competitiveness [5] Summary by Sections Revenue Performance - In H1 2025, the company achieved revenue of 161.42 billion yuan, up 29.51% year-on-year, with Q2 revenue at 79.36 billion yuan, a 21.84% increase year-on-year [3] - The electronic process equipment segment generated 152.58 billion yuan in revenue, a 33.89% increase year-on-year, contributing over 85% to total revenue [3] - The electronic components segment saw a revenue decline of 17.47% year-on-year, impacting overall revenue performance [3] Profitability Analysis - The net profit attributable to the parent company for H1 2025 was 32.08 billion yuan, a 14.97% increase year-on-year, while the net profit margin decreased slightly [4] - The overall gross profit margin for 2025 was 42.17%, down 3.33 percentage points year-on-year, influenced by changes in product mix and industry conditions [4] - R&D expenses for H1 2025 were 29.15 billion yuan, with a capitalized R&D expense ratio of 28.75%, contributing to the decline in net profit margin [4] Strategic Outlook - The company is expected to benefit from the expansion of advanced processes in the semiconductor industry over the next five years [5] - The acquisition of Chip Source Microelectronics is anticipated to enhance the company's competitive position in the market [5] - The strategic significance of acquisitions is highlighted, with comparisons to global leaders in specific segments [5] Financial Forecast - Revenue forecasts for 2025-2027 are projected at 390.58 billion yuan, 484.54 billion yuan, and 601.63 billion yuan, with respective year-on-year growth rates of 30.9%, 24.1%, and 24.2% [7] - Net profit forecasts for the same period are 76.37 billion yuan, 101.56 billion yuan, and 128.55 billion yuan, with year-on-year growth rates of 35.9%, 33.0%, and 26.6% [7] - The estimated EPS for 2025-2027 is 10.58 yuan, 14.07 yuan, and 17.82 yuan, respectively [7]

格隆汇8月29日丨晶升股份(688478.SH)发布2025年半年度报告，报告期实现营业收入1.58亿元，同比下 降20.29%；归属上市公司股东的净利润-745.09万元，同比下降121.29%；扣除非经常性损益后的归属于 上市公司股东的净利润-0.2亿元，同比下降213.81%；基本每股收益-0.05元。 ...

Core Insights - The company reported a revenue of 2,016.87 million, an increase of 8.88% compared to the same period last year, while net profit attributable to shareholders decreased by 10.20% to 942.41 million [1][2] - The semiconductor business revenue share increased to 57%, indicating a strong focus on the semiconductor industry and successful expansion into emerging markets [2] - The company has a robust contract backlog, which supports the expectation of continued performance growth throughout the year [2][3] Financial Performance - Revenue for the first half of the year was 2,016,868,258.75, up from 1,852,329,471.27, reflecting an 8.88% increase [1] - Net profit attributable to shareholders was 94,240,854.86, down 10.20% from 104,944,006.07 [1] - The net profit after deducting non-recurring gains and losses was 58,801,885.63, a significant decline of 48.45% from 114,063,784.25 [1] Strategic Developments - The company is actively expanding its presence in the semiconductor sector while also venturing into advanced manufacturing markets, which now account for 18.5% of its revenue [2] - The acquisition of a 62.23% stake in Liaoning Hanjing Semiconductor Materials Co., Ltd. is expected to enhance the company's capabilities in core semiconductor components and drive growth in OPEX business [3] - The company aims to strengthen its core competitiveness by focusing on domestic alternatives in high-consumption components [2][3]

证券研究报告 | 公司点评报告 2025 年 08 月 29 日 中微公司（688012.SH） 25Q2 利润同比稳健增长，加快研发投入和新品推出节奏 TMT 及中小盘/电子 中微公司发布 2025 半年报，25Q2 收入同比高增长，利润稳健增长，公司加大 研发投入以加速新品推出节奏，刻蚀设备在先进制程工艺产线持续上量，EPI 等新品验证进展顺利。维持"增持"投资评级。 ❑ 风险提示：下游晶圆厂扩产不及预期，晶圆厂产能利用率下滑的风险，新品 研发不及预期，行业竞争加剧的风险。 | 财务数据与估值 | | | | | | | --- | --- | --- | --- | --- | --- | | 会计年度 | 2023 | 2024 | 2025E | 2026E | 2027E | | 营业总收入(百万元) | 6264 | 9065 | 11929 | 15121 | 18500 | | 同比增长 | 32% | 45% | 32% | 27% | 22% | | 营业利润(百万元) | 1980 | 1704 | 2394 | 3233 | 4212 | | 同比增长 | 57% | -14% | ...